Загрузка...
Effects of pre-transplant L-carnitine supplementation on primary graft dysfunction in liver transplant recipients: a pilot, randomized, placebo-controlled clinical trial
Primary graft dysfunction (PGD) and non-function (PNF) happen in 8.7-24.7% and 0.9-7.2% of liver transplant recipients, respectively. These phenomena increase treatment cost and patients’ death. This study assessed the effect of L-carnitine supplementation on the incidences of PNF/PGD in liver trans...
Сохранить в:
| Опубликовано в: : | Res Pharm Sci |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer - Medknow
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6937745/ https://ncbi.nlm.nih.gov/pubmed/32038730 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.272537 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|